Saudi Central Bank Acquires 3,965 Shares of Humana Inc. $HUM

Saudi Central Bank lifted its holdings in Humana Inc. (NYSE:HUM) by 89.3% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 8,404 shares of the insurance provider’s stock after purchasing an additional 3,965 shares during the period. Saudi Central Bank’s holdings in Humana were worth $3,338,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HUM. Johnson Financial Group Inc. bought a new stake in Humana during the 2nd quarter valued at $26,000. Fideuram Asset Management Ireland dac purchased a new stake in shares of Humana during the 4th quarter worth $27,000. Trust Co. of Vermont purchased a new position in Humana in the second quarter valued at about $28,000. Reflection Asset Management purchased a new position in Humana in the fourth quarter valued at about $29,000. Finally, Bogart Wealth LLC raised its holdings in Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Trading Down 0.2%

Humana stock opened at $400.70 on Tuesday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The company has a market capitalization of $48.12 billion, a price-to-earnings ratio of 37.91, a price-to-earnings-growth ratio of 2.63 and a beta of 0.74. The stock has a 50-day moving average price of $388.67 and a 200 day moving average price of $298.31.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the prior year, the business earned $6.27 earnings per share. The business’s quarterly revenue was up 26.2% compared to the same quarter last year. Sell-side analysts anticipate that Humana Inc. will post 9 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana’s payout ratio is currently 33.49%.

Analyst Ratings Changes

HUM has been the topic of a number of recent analyst reports. Robert W. Baird set a $390.00 price target on shares of Humana in a report on Thursday, July 30th. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Guggenheim lifted their price target on shares of Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Lake Street Capital began coverage on Humana in a research report on Thursday, July 30th. They set a “buy” rating on the stock. Finally, Morgan Stanley raised Humana from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $249.00 to $370.00 in a research report on Tuesday, August 4th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $403.91.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.